Dickinson Klara
Insider CIK 1339895 · CBAY See Remarks · ANTH Chief Regulatory Officer · HPTX SVP Reg. Affairs & Compliance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 138,312 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 175,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 66,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 328,299 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 215,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 100,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 200,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 78,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 21,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 78,000 | — | $0 | 78,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award | 2024-01-24 | 2024-01-26 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 66,500 | — | $0 | 66,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 328,299 | — | $0 | 328,299 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 138,312 | — | $0 | 138,312 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2017-05-20 | 2017-05-22 | 43,750 | — | $0 | 43,750 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-06-09 | 2016-06-13 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-02-12 | 2016-02-16 | 8,395 | — | $0 | 8,395 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-03-11 | 2014-03-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-03-11 | 2014-03-13 | 2,000 | — | $0 | 2,283 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-04-15 | 2013-05-01 | 43,000 | — | $0 | 43,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 278 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 278 | — | $0 | 283 | SEC↗ |